These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 32434109)
1. Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer. Matsuo K; Matsuzaki S; Nusbaum DJ; Machida H; Nagase Y; Grubbs BH; Roman LD; Wright JD; Harter P; Klar M Eur J Cancer; 2020 Jul; 133():33-46. PubMed ID: 32434109 [TBL] [Abstract][Full Text] [Related]
2. Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer. Matsuo K; Nusbaum DJ; Matsuzaki S; Chang EJ; Roman LD; Wright JD; Harter P; Klar M Gynecol Oncol; 2020 Oct; 159(1):43-51. PubMed ID: 32690393 [TBL] [Abstract][Full Text] [Related]
3. Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer. Matsuo K; Yabuno A; Hom MS; Shida M; Kakuda M; Adachi S; Mandelbaum RS; Ueda Y; Hasegawa K; Enomoto T; Mikami M; Roman LD Gynecol Oncol; 2018 May; 149(2):301-309. PubMed ID: 29605499 [TBL] [Abstract][Full Text] [Related]
4. Trends in peritoneal cytology evaluation at hysterectomy for endometrial cancer in the United States. Matsuo K; Klar M; Harter P; Miller H; Nusbaum DJ; Matsuzaki S; Roman LD; Wright JD Gynecol Oncol; 2021 Jun; 161(3):710-719. PubMed ID: 33726962 [TBL] [Abstract][Full Text] [Related]
5. Clinico-pathological significance of suspicious peritoneal cytology in endometrial cancer. Matsuo K; Matsuzaki S; Miller H; Nusbaum DJ; Walia S; Matsuzaki S; Shimada M; Klar M; Roman LD J Surg Oncol; 2021 Sep; 124(4):687-698. PubMed ID: 34118157 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer. Scott SA; van der Zanden C; Cai E; McGahan CE; Kwon JS Gynecol Oncol; 2017 May; 145(2):262-268. PubMed ID: 28359690 [TBL] [Abstract][Full Text] [Related]
7. Association Between Adjuvant Therapy and Survival in Stage II-III Endometrial Cancer: Influence of Malignant Peritoneal Cytology. Matsuo K; Matsuzaki S; Nusbaum DJ; Roman LD; Wright JD; Harter P; Klar M Ann Surg Oncol; 2021 Nov; 28(12):7591-7603. PubMed ID: 33797002 [TBL] [Abstract][Full Text] [Related]
8. Prognosis and treatment of positive peritoneal cytology in early endometrial cancer: matched cohort analyses from the National Cancer Database. Seagle BL; Alexander AL; Lantsman T; Shahabi S Am J Obstet Gynecol; 2018 Mar; 218(3):329.e1-329.e15. PubMed ID: 29223598 [TBL] [Abstract][Full Text] [Related]
9. Peritoneal cytology: a risk factor of recurrence for non-endometrioid endometrial cancer. Han KH; Park NH; Kim HS; Chung HH; Kim JW; Song YS Gynecol Oncol; 2014 Aug; 134(2):293-6. PubMed ID: 24854062 [TBL] [Abstract][Full Text] [Related]
10. [Clinical implications of positive peritoneal cytology in endometrial cancer]. Ren YL; Wang HY; Shan BE; Ping B; Shi DR Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):595-9. PubMed ID: 22169518 [TBL] [Abstract][Full Text] [Related]
11. Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer. Matsuo K; Machida H; Frimer M; Marcus JZ; Pejovic T; Roman LD; Wright JD Gynecol Oncol; 2017 Dec; 147(3):558-564. PubMed ID: 28986093 [TBL] [Abstract][Full Text] [Related]
12. Prognosis of women with apparent stage I endometrial cancer who had supracervical hysterectomy. Matsuo K; Machida H; Takiuchi T; Garcia-Sayre J; Yessaian AA; Roman LD Gynecol Oncol; 2017 Apr; 145(1):41-49. PubMed ID: 28215841 [TBL] [Abstract][Full Text] [Related]
13. Prognosis and adjuvant chemotherapy for patients with malignant peritoneal cytology in early-stage non-endometrioid endometrial cancer. Tang X; Li N; Hu Y Eur J Surg Oncol; 2023 Nov; 49(11):107071. PubMed ID: 37708662 [TBL] [Abstract][Full Text] [Related]
14. Patient compliance for postoperative radiotherapy and survival outcome of women with stage I endometrioid endometrial cancer. Matsuo K; Machida H; Ragab OM; Garcia-Sayre J; Yessaian AA; Roman LD J Surg Oncol; 2017 Sep; 116(4):482-491. PubMed ID: 28543055 [TBL] [Abstract][Full Text] [Related]
15. The prognostic role of peritoneal cytology in stage IA endometrial endometrioid carcinomas. Wang L; Li L; Wu M; Lang J Curr Probl Cancer; 2020 Apr; 44(2):100514. PubMed ID: 31753315 [TBL] [Abstract][Full Text] [Related]
16. Defining the survival benefit of adjuvant pelvic radiotherapy and chemotherapy versus chemotherapy alone in stages III-IVA endometrial carcinoma. Xiang M; English DP; Kidd EA Gynecol Oncol; 2019 Sep; 154(3):487-494. PubMed ID: 31257010 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy in early-stage endometrioid endometrial cancer with >50% myometrial invasion and negative lymph nodes. Multinu F; Garzon S; Weaver AL; McGree ME; Sartori E; Landoni F; Zola P; Dinoi G; Aletti G; Block MS; Gadducci A; Mariani A Int J Gynecol Cancer; 2021 Apr; 31(4):537-544. PubMed ID: 33608453 [TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment. Cosgrove CM; Cohn DE; Rhoades J; Felix AS Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714 [TBL] [Abstract][Full Text] [Related]
19. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis. Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700 [TBL] [Abstract][Full Text] [Related]
20. Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer. Garg G; Gao F; Wright JD; Hagemann AR; Mutch DG; Powell MA Gynecol Oncol; 2013 Jan; 128(1):77-82. PubMed ID: 23032094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]